Vés al contingut

Comparative safety and efficacy study of two atrophic rhinitis vaccines in gilts

Publicacions
Porcí
Autors

Acal, L.; Montané, J.; Camprodon, A.; Pedrazuela, R.; March, R.

Aparegut a

ESPHM Congress, 2016

The aim of this study was to evaluate and compare the efficacy and safety of two commercially available vaccines for the prevention of atrophic rhinitis (AR) in swine by comparing the serological response and the body temperature increase after vaccination. RHINISENG® is a vaccine for the prevention of progressive and non-progressive AR in swine, which contains HIPRAMUNE® Gd as an adjuvant. The other commercial vaccine used in this study is based on dl-α-tocopherol and is only indicated against progressive AR.

Descarrega aquest article
PDF